These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3085442

  • 1. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
    Takahashi Y, Akagi Y, Akimune M, Tamura K, Itoi M.
    Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
    [No Abstract] [Full Text] [Related]

  • 2. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
    Terubayashi H, Akagi Y, Takahashi Y, Ikebe H, Miyamoto Y, Ibaraki N, Yokoi N, Tutumi M, Itoi M.
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
    [No Abstract] [Full Text] [Related]

  • 3. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y, Takahashi Y, Tanabe T, Ikebe H, Majima K, Miyatani H, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
    [No Abstract] [Full Text] [Related]

  • 4. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
    Ohashi Y, Matsuda M, Hosotani H, Tano Y, Ishimoto I, Fukuda M, Manabe R.
    Am J Ophthalmol; 1988 Mar 15; 105(3):233-8. PubMed ID: 3125744
    [Abstract] [Full Text] [Related]

  • 5. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition.
    Vinores SA, Campochiaro PA.
    Exp Eye Res; 1989 Sep 15; 49(3):495-510. PubMed ID: 2507341
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 15; 91(2):246-53. PubMed ID: 3111200
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Adv Exp Med Biol; 1979 Feb 15; 119():347-56. PubMed ID: 115231
    [No Abstract] [Full Text] [Related]

  • 8. [Ciliary body changes associate with aldose reductase in galactosemic rats].
    Ikebe H, Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1989 Jul 15; 93(7):758-62. PubMed ID: 2514592
    [Abstract] [Full Text] [Related]

  • 9. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
    Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Mar 15; 92(3):484-8. PubMed ID: 3137794
    [No Abstract] [Full Text] [Related]

  • 10. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
    Terubayashi H, Akagi Y.
    Jpn J Ophthalmol; 1989 Mar 15; 33(3):343-7. PubMed ID: 2507812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S, Rechthand E, Terubayashi H, Palestine A, Rapoport S, Kador P.
    Diabetes; 1987 Nov 15; 36(11):1271-5. PubMed ID: 3117606
    [Abstract] [Full Text] [Related]

  • 14. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF, Kinoshita JH, Terubayashi H, Akagi Y, Kador PF, Kinoshita JH.
    Nippon Ganka Gakkai Zasshi; 1988 Oct 15; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract] [Full Text] [Related]

  • 15. Effects of an aldose reductase inhibitor, 1-[(p-bromophenyl)-sulfonyl]hydantoin, on cataract formation and tissue polyol levels in galactosemic rats.
    Okuda J, Yashima K, Inagaki K, Miwa I.
    Chem Pharm Bull (Tokyo); 1985 Jul 15; 33(7):2990-5. PubMed ID: 3936627
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Nippon Ganka Gakkai Zasshi; 1985 Oct 15; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract] [Full Text] [Related]

  • 17. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 15; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 18. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S, Simmons DA, Kern EF.
    Trans Assoc Am Physicians; 1986 Jan 15; 99():67-72. PubMed ID: 3111062
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention and reversal of rat galactosemic cataract with aldose reductase inhibitor--immunohistochemical study].
    Akagi Y, Kador PF, Kinoshita JH, Tasaka H, Nakaji Y, Itoi M.
    Nippon Ganka Gakkai Zasshi; 1985 Nov 15; 89(11):1276-81. PubMed ID: 3937449
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.